(IMMR) Immersion - Overview
Sector: TechnologyIndustry: Software - Application | Exchange NASDAQ (USA) | Currency USD | Market Cap: 216m | Total Return -24.5% in 12m
Stock: Touch Technology, Software, Licensing, Textbooks, Marketing
Total Rating 36
Risk 29
Buy Signal -1.20
| Risk 5d forecast | |
|---|---|
| Volatility | 55.2% |
| Relative Tail Risk | -6.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.78 |
| Alpha | -42.79 |
| Character TTM | |
|---|---|
| Beta | 1.267 |
| Beta Downside | 1.723 |
| Drawdowns 3y | |
|---|---|
| Max DD | 56.13% |
| CAGR/Max DD | -0.21 |
EPS (Earnings per Share)
Revenue
Description: IMMR Immersion March 04, 2026
Immersion Corporation (IMMR) specializes in haptic technology, owning intellectual property that simulates the sense of touch in digital devices. Haptic technology is increasingly integrated into user interfaces across various industries.
The company licenses its patented technology, software, and tools. This business model is common for IP-centric firms, where revenue is generated through licensing agreements rather than direct product sales.
IMMRs technology serves diverse markets including mobile, gaming, automotive, and medical devices. The automotive sector, for example, is increasingly incorporating haptic feedback for controls and alerts.
For a deeper dive into IMMRs financials and market position, consider exploring ValueRay.
Headlines to watch out for
- New licensing agreements expand haptic technology market penetration
- Royalty revenue from existing patents drives financial performance
- Litigation outcomes impact intellectual property valuation
- Automotive industry adoption of haptics boosts future growth
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 7.95m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.04 > 0.02 and ΔFCF/TA -0.50 > 1.0 |
| NWC/Revenue: 16.12% < 20% (prev 147.6%; Δ -131.5% < -1%) |
| CFO/TA -0.03 > 3% & CFO -33.3m > Net Income 7.95m |
| Net Debt (182.4m) to EBITDA (125.0m): 1.46 < 3 |
| Current Ratio: 1.75 > 1.5 & < 3 |
| Outstanding Shares: last quarter (32.6m) vs 12m ago 0.28% < -2% |
| Gross Margin: 91.09% > 18% (prev 0.75%; Δ 9.03k% > 0.5%) |
| Asset Turnover: 145.4% > 50% (prev 13.74%; Δ 131.6% > 0%) |
| Interest Coverage Ratio: 4.85 > 6 (EBITDA TTM 125.0m / Interest Expense TTM 19.6m) |
Altman Z'' 2.30
| A: 0.24 (Total Current Assets 626.3m - Total Current Liabilities 358.0m) / Total Assets 1.10b |
| B: 0.03 (Retained Earnings 32.3m / Total Assets 1.10b) |
| C: 0.08 (EBIT TTM 95.3m / Avg Total Assets 1.14b) |
| D: 0.05 (Book Value of Equity 32.7m / Total Liabilities 715.6m) |
| Altman-Z'' Score: 2.30 = BBB |
Beneish M 1.00
| DSRI: 0.07 (Receivables 108.6m/143.8m, Revenue 1.66b/163.1m) |
| GMI: 0.82 (GM 91.09% / 74.88%) |
| AQI: 1.16 (AQ_t 0.20 / AQ_t-1 0.18) |
| SGI: 10.20 (Revenue 1.66b / 163.1m) |
| TATA: 0.04 (NI 7.95m - CFO -33.3m) / TA 1.10b) |
| Beneish M-Score: 2.78 (Cap -4..+1) = D |
What is the price of IMMR shares?
As of March 30, 2026, the stock is trading at USD 5.55 with a total of 1,025,912 shares traded.
Over the past week, the price has changed by -8.72%, over one month by -9.17%, over three months by -17.44% and over the past year by -24.51%.
Over the past week, the price has changed by -8.72%, over one month by -9.17%, over three months by -17.44% and over the past year by -24.51%.
Is IMMR a buy, sell or hold?
Immersion has received a consensus analysts rating of 4.50.
Therefore, it is recommended to buy IMMR.
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the IMMR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 13.5 | 143.2% |
| Analysts Target Price | 13.5 | 143.2% |
IMMR Fundamental Data Overview March 28, 2026
P/E Trailing = 3.5944
P/E Forward = 14.6199
P/S = 0.1255
P/B = 0.6858
P/EG = -0.45
Revenue TTM = 1.66b USD
EBIT TTM = 95.3m USD
EBITDA TTM = 125.0m USD
Long Term Debt = 103.1m USD (from longTermDebt, last fiscal year)
Short Term Debt = 46.4m USD (from shortTermDebt, last quarter)
Debt = 182.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 182.4m USD (from netDebt column, last quarter)
Enterprise Value = 219.8m USD (216.1m + Debt 182.4m - CCE 178.7m)
Interest Coverage Ratio = 4.85 (Ebit TTM 95.3m / Interest Expense TTM 19.6m)
EV/FCF = -4.64x (Enterprise Value 219.8m / FCF TTM -47.4m)
FCF Yield = -21.55% (FCF TTM -47.4m / Enterprise Value 219.8m)
FCF Margin = -2.84% (FCF TTM -47.4m / Revenue TTM 1.66b)
Net Margin = 0.48% (Net Income TTM 7.95m / Revenue TTM 1.66b)
Gross Margin = 91.09% ((Revenue TTM 1.66b - Cost of Revenue TTM 148.4m) / Revenue TTM)
Gross Margin QoQ = 36.07% (prev none%)
Tobins Q-Ratio = 0.20 (Enterprise Value 219.8m / Total Assets 1.10b)
Interest Expense / Debt = 4.25% (Interest Expense 7.74m / Debt 182.4m)
Taxrate = 25.51% (39.3m / 154.1m)
NOPAT = 71.0m (EBIT 95.3m * (1 - 25.51%))
Current Ratio = 1.75 (Total Current Assets 626.3m / Total Current Liabilities 358.0m)
Debt / Equity = 0.62 (Debt 182.4m / totalStockholderEquity, last quarter 295.8m)
Debt / EBITDA = 1.46 (Net Debt 182.4m / EBITDA 125.0m)
Debt / FCF = -3.85 (negative FCF - burning cash) (Net Debt 182.4m / FCF TTM -47.4m)
Total Stockholder Equity = 306.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.69% (Net Income 7.95m / Total Assets 1.10b)
RoE = 2.60% (Net Income TTM 7.95m / Total Stockholder Equity 306.0m)
RoCE = 23.28% (EBIT 95.3m / Capital Employed (Equity 306.0m + L.T.Debt 103.1m))
RoIC = 15.77% (NOPAT 71.0m / Invested Capital 450.0m)
WACC = 7.11% (E(216.1m)/V(398.5m) * Re(10.44%) + D(182.4m)/V(398.5m) * Rd(4.25%) * (1-Tc(0.26)))
Discount Rate = 10.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.14%
[DCF] Fair Price = unknown (Cash Flow -47.4m)
EPS Correlation: -5.58 | EPS CAGR: -14.57% | SUE: -0.42 | # QB: 0
Revenue Correlation: 85.59 | Revenue CAGR: 168.7% | SUE: 4.0 | # QB: 3
EPS next Year (2026-04-30): EPS=0.42 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=-76.9% | Growth Revenue=+5.2%
P/E Forward = 14.6199
P/S = 0.1255
P/B = 0.6858
P/EG = -0.45
Revenue TTM = 1.66b USD
EBIT TTM = 95.3m USD
EBITDA TTM = 125.0m USD
Long Term Debt = 103.1m USD (from longTermDebt, last fiscal year)
Short Term Debt = 46.4m USD (from shortTermDebt, last quarter)
Debt = 182.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 182.4m USD (from netDebt column, last quarter)
Enterprise Value = 219.8m USD (216.1m + Debt 182.4m - CCE 178.7m)
Interest Coverage Ratio = 4.85 (Ebit TTM 95.3m / Interest Expense TTM 19.6m)
EV/FCF = -4.64x (Enterprise Value 219.8m / FCF TTM -47.4m)
FCF Yield = -21.55% (FCF TTM -47.4m / Enterprise Value 219.8m)
FCF Margin = -2.84% (FCF TTM -47.4m / Revenue TTM 1.66b)
Net Margin = 0.48% (Net Income TTM 7.95m / Revenue TTM 1.66b)
Gross Margin = 91.09% ((Revenue TTM 1.66b - Cost of Revenue TTM 148.4m) / Revenue TTM)
Gross Margin QoQ = 36.07% (prev none%)
Tobins Q-Ratio = 0.20 (Enterprise Value 219.8m / Total Assets 1.10b)
Interest Expense / Debt = 4.25% (Interest Expense 7.74m / Debt 182.4m)
Taxrate = 25.51% (39.3m / 154.1m)
NOPAT = 71.0m (EBIT 95.3m * (1 - 25.51%))
Current Ratio = 1.75 (Total Current Assets 626.3m / Total Current Liabilities 358.0m)
Debt / Equity = 0.62 (Debt 182.4m / totalStockholderEquity, last quarter 295.8m)
Debt / EBITDA = 1.46 (Net Debt 182.4m / EBITDA 125.0m)
Debt / FCF = -3.85 (negative FCF - burning cash) (Net Debt 182.4m / FCF TTM -47.4m)
Total Stockholder Equity = 306.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.69% (Net Income 7.95m / Total Assets 1.10b)
RoE = 2.60% (Net Income TTM 7.95m / Total Stockholder Equity 306.0m)
RoCE = 23.28% (EBIT 95.3m / Capital Employed (Equity 306.0m + L.T.Debt 103.1m))
RoIC = 15.77% (NOPAT 71.0m / Invested Capital 450.0m)
WACC = 7.11% (E(216.1m)/V(398.5m) * Re(10.44%) + D(182.4m)/V(398.5m) * Rd(4.25%) * (1-Tc(0.26)))
Discount Rate = 10.44% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.14%
[DCF] Fair Price = unknown (Cash Flow -47.4m)
EPS Correlation: -5.58 | EPS CAGR: -14.57% | SUE: -0.42 | # QB: 0
Revenue Correlation: 85.59 | Revenue CAGR: 168.7% | SUE: 4.0 | # QB: 3
EPS next Year (2026-04-30): EPS=0.42 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=-76.9% | Growth Revenue=+5.2%